View ValuationQualisys Holding 향후 성장Future 기준 점검 3/6Qualisys Holding (는) 각각 연간 15.6% 및 6.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 15.6% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 23.3% 로 예상됩니다.핵심 정보15.6%이익 성장률15.57%EPS 성장률Electronic 이익 성장35.3%매출 성장률6.9%향후 자기자본이익률23.35%애널리스트 커버리지Low마지막 업데이트23 Jun 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • 6hLess than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Board Member Jenny Rosberg was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Jun 12Qualisys Holding AB Expands Markerless Motion Capture Portfolio with Prisma Pose Built for Biomechanics LabsQualisys Holding AB introduced Prisma Pose, a new engine that integrates markerless skeletal tracking directly into Qualisys Track Manager (QTM), eliminating the need for software for third-party biomechanics laboratories. Prisma Pose is proprietary Qualisys technology that expands the markerless portfolio with an offering that covers the company's full spectrum of needs across sport, clinical, and research. Prisma Pose is designed to give biomechanics laboratories a practical and accessible markerless tracking solution, with no need for additional software vendors or hardware investments. Alongside OnTraq, for performance analysis in elite sport, and purpose-built Qualisys' partnership with Theia for laboratories with more extensive requirements, Qualisys now offers a complete suite of markerless solutions, tailored to the needs and ambitions of each organization. Running markerless motion capture in a lab typically requires a second QTM-based software stack - a separate license and additional steps to align markerless output with optical, force plate, and EMG data. Prisma Pose brings the full markerless processing chain inside QTM, with automatic synchronization across all data streams and direct integration into existing Qualisys analysis modules and Web Reports. Support is covered under existing Qualisys plans. Prisma Pose engine integrated in QTM also powers OnTraq. Two years of real-world deployment of OnTraq have sharpened the understanding of what biomechanics labs need from markerless capture, and that experience is built directly into Prisma Pose. Prisma Pose is validated for the most common biomechanical assessment tasks - making it well suited for labs conducting routine movement assessments, rehabilitation research, and sports science studies. Biomechanics labs using QTM can access Prisma Pose as an add-on license in the Fourth Quarter of 2026 when it will be launched. Qualisys Holding AB will showcase QTM with Prisma Pose at the World Congress of Biomechanics and the International Society of Biomechanics in Sports conference in the summer, as well as at several regional events during the fall. Demand for markerless capture is growing as labs seek to reduce participant burden and reach populations where marker attachment is not practical. Unlike competitors who license markerless software, Qualisys Holding AB has developed its own proprietary engine, giving the company full control over its roadmap and a strong and independent position in the markerless segment. For Qualisys Holding AB, Prisma Pose represents incremental license add-on revenue from customers who have already made the primary hardware investment. With OnTraq, Prisma Pose, and through the Theia partnership, Qualisys Holding AB offers a differentiated product portfolio across the full markerless spectrum - one of the fastest-growing segments in human movement research.Reported Earnings • May 21First quarter 2026 earnings released: kr0.36 loss per share (vs kr0.12 profit in 1Q 2025)First quarter 2026 results: kr0.36 loss per share (down from kr0.12 profit in 1Q 2025). Revenue: kr45.4m (down 25% from 1Q 2025). Net loss: kr3.58m (down 402% from profit in 1Q 2025). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electronic industry in Germany.공시 • Dec 20+ 4 more updatesQualisys Holding AB (publ) to Report Nine Months, 2026 Results on Nov 12, 2026Qualisys Holding AB (publ) announced that they will report nine months, 2026 results on Nov 12, 2026공시 • Nov 11Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026. Location: gothenburg Sweden공시 • May 14Qualisys Holding AB (publ) announces Annual dividend, payable on May 21, 2025Qualisys Holding AB (publ) announced Annual dividend of SEK 3.0000 per share payable on May 21, 2025, ex-date on May 15, 2025 and record date on May 16, 2025.공시 • Apr 14+ 1 more updateQualisys Holding AB (publ), Annual General Meeting, May 14, 2025Qualisys Holding AB (publ), Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time. Location: at the companys premises at, kvarnbergsgatan 2, gothenburg Sweden이익 및 매출 성장 예측DB:R0A - 애널리스트 향후 추정치 및 과거 재무 데이터 (SEK Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028299473645112/31/2027277412837112/31/202625232374513/31/2026250322234N/A12/31/2025269372031N/A9/30/2025260323645N/A6/30/2025268384453N/A3/31/2025264394552N/A12/31/2024254405462N/A12/31/2023249393042N/A12/31/2022233453338N/A12/31/2021180231721N/A12/31/2020145162026N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: R0A 의 연간 예상 수익 증가율(15.6%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: R0A 의 연간 수익(15.6%)이 German 시장(16.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: R0A 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: R0A 의 수익(연간 6.9%)이 German 시장(연간 6.6%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: R0A 의 수익(연간 6.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: R0A의 자본 수익률은 3년 후 23.3%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YTech 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/24 13:46종가2026/06/24 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Qualisys Holding AB (publ)는 1명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jakob SöderblomDNB Carnegie Commissioned Research
Board Change • 6hLess than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Board Member Jenny Rosberg was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Jun 12Qualisys Holding AB Expands Markerless Motion Capture Portfolio with Prisma Pose Built for Biomechanics LabsQualisys Holding AB introduced Prisma Pose, a new engine that integrates markerless skeletal tracking directly into Qualisys Track Manager (QTM), eliminating the need for software for third-party biomechanics laboratories. Prisma Pose is proprietary Qualisys technology that expands the markerless portfolio with an offering that covers the company's full spectrum of needs across sport, clinical, and research. Prisma Pose is designed to give biomechanics laboratories a practical and accessible markerless tracking solution, with no need for additional software vendors or hardware investments. Alongside OnTraq, for performance analysis in elite sport, and purpose-built Qualisys' partnership with Theia for laboratories with more extensive requirements, Qualisys now offers a complete suite of markerless solutions, tailored to the needs and ambitions of each organization. Running markerless motion capture in a lab typically requires a second QTM-based software stack - a separate license and additional steps to align markerless output with optical, force plate, and EMG data. Prisma Pose brings the full markerless processing chain inside QTM, with automatic synchronization across all data streams and direct integration into existing Qualisys analysis modules and Web Reports. Support is covered under existing Qualisys plans. Prisma Pose engine integrated in QTM also powers OnTraq. Two years of real-world deployment of OnTraq have sharpened the understanding of what biomechanics labs need from markerless capture, and that experience is built directly into Prisma Pose. Prisma Pose is validated for the most common biomechanical assessment tasks - making it well suited for labs conducting routine movement assessments, rehabilitation research, and sports science studies. Biomechanics labs using QTM can access Prisma Pose as an add-on license in the Fourth Quarter of 2026 when it will be launched. Qualisys Holding AB will showcase QTM with Prisma Pose at the World Congress of Biomechanics and the International Society of Biomechanics in Sports conference in the summer, as well as at several regional events during the fall. Demand for markerless capture is growing as labs seek to reduce participant burden and reach populations where marker attachment is not practical. Unlike competitors who license markerless software, Qualisys Holding AB has developed its own proprietary engine, giving the company full control over its roadmap and a strong and independent position in the markerless segment. For Qualisys Holding AB, Prisma Pose represents incremental license add-on revenue from customers who have already made the primary hardware investment. With OnTraq, Prisma Pose, and through the Theia partnership, Qualisys Holding AB offers a differentiated product portfolio across the full markerless spectrum - one of the fastest-growing segments in human movement research.
Reported Earnings • May 21First quarter 2026 earnings released: kr0.36 loss per share (vs kr0.12 profit in 1Q 2025)First quarter 2026 results: kr0.36 loss per share (down from kr0.12 profit in 1Q 2025). Revenue: kr45.4m (down 25% from 1Q 2025). Net loss: kr3.58m (down 402% from profit in 1Q 2025). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Electronic industry in Germany.
공시 • Dec 20+ 4 more updatesQualisys Holding AB (publ) to Report Nine Months, 2026 Results on Nov 12, 2026Qualisys Holding AB (publ) announced that they will report nine months, 2026 results on Nov 12, 2026
공시 • Nov 11Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026Qualisys Holding AB (publ), Annual General Meeting, May 18, 2026. Location: gothenburg Sweden
공시 • May 14Qualisys Holding AB (publ) announces Annual dividend, payable on May 21, 2025Qualisys Holding AB (publ) announced Annual dividend of SEK 3.0000 per share payable on May 21, 2025, ex-date on May 15, 2025 and record date on May 16, 2025.
공시 • Apr 14+ 1 more updateQualisys Holding AB (publ), Annual General Meeting, May 14, 2025Qualisys Holding AB (publ), Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time. Location: at the companys premises at, kvarnbergsgatan 2, gothenburg Sweden